Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.

dc.contributor.authorFares Otero, Natalia Elena
dc.contributor.authorLeucht S
dc.contributor.authorSeedat S
dc.date.accessioned2026-02-27T10:20:09Z
dc.date.embargoEndDateinfo:eu-repo/date/embargoEnd/2026-08-18
dc.date.issued2026-02-18
dc.date.updated2026-02-26T09:57:23Z
dc.description.abstractSchizophrenia spectrum disorders (SSD) are among the leading global causes of disability, owing to chronic trajectories and high rates of treatment resistance. Antipsychotic medications are generally effective, but in up to a third of individuals with an acute episode, their symptoms show insufficient treatment response, underscoring the need to identify predictors of poor outcomes.eng
dc.embargo.lift2026-08-18
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina9492867
dc.identifier.issnFares N; Leucht S; Seedat S (2026). Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.. Lancet Psychiatry, (), S2215-8. DOI: 10.1016/S2215-0366(26)00025-8
dc.identifier.urihttps://hdl.handle.net/2445/227620
dc.language.isoEnglish
dc.relation.isformatofhttps://doi.org/10.1016/S2215-0366(26)00025-8
dc.relation.ispartofLancet Psychiatry, 2026, S2215-8
dc.relation.urihttps://doi.org/10.1016/S2215-0366(26)00025-8
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectBiological psychiatry
dc.subjectCiências biológicas ii
dc.subjectEngenharias iv
dc.subjectGeneral medicine
dc.subjectMedicina i
dc.subjectMedicina ii
dc.subjectPsychiatry
dc.subjectPsychiatry and mental health
dc.subjectSaúde coletiva
dc.titleAssessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.
dc.typepreprint

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.pdf
Mida:
247.18 KB
Format:
Adobe Portable Document Format